Evidence map›Paper›PMID 25428144›Full record

ArticleJournal of clinical microbiology2015

High-throughput mycobacterial interspersed repetitive-unit-variable-number tandem-repeat genotyping for Mycobacterium tuberculosis epidemiological studies.

Marie Gauthier, Floriane Bidault, Amandine Mosnier, Nino Bablishvili, Nestani Tukvadze, Silaphet Somphavong, Phimpha Paboriboune, Oksana Ocheretina, Jean William Pape, Glaucia Paranhos-Baccala and 1 more

Abstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Heterogeneity of Mycobacterium tuberculosis Strains Circulating in Panama's Western Region.The American journal of tropical medicine and hygiene · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Exploring the usefulness of molecular epidemiology of tuberculosis in Africa: a systematic review.International journal of molecular epidemiology and genetics · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Marie GauthierLaboratoire des Pathogènes Emergents (LPE), Fondation Mérieux-Centre International de Recherche en Infectiologie (CIRI), Lyon, France marie.gauthier@fondation-merieux.org.
Floriane BidaultLaboratoire des Pathogènes Emergents (LPE), Fondation Mérieux-Centre International de Recherche en Infectiologie (CIRI), Lyon, France.
Amandine MosnierLaboratoire des Pathogènes Emergents (LPE), Fondation Mérieux-Centre International de Recherche en Infectiologie (CIRI), Lyon, France.
Nino BablishviliNational Center for Tuberculosis and Lung Disease (NCTLD), Tbilisi, Georgia.
Nestani TukvadzeNational Center for Tuberculosis and Lung Disease (NCTLD), Tbilisi, Georgia.
Silaphet SomphavongCentre d'Infectiologie Christophe Mérieux du Laos (CICML), Vientiane, Lao People's Democratic Republic.
Phimpha PaboribouneCentre d'Infectiologie Christophe Mérieux du Laos (CICML), Vientiane, Lao People's Democratic Republic.
Oksana OcheretinaLes Centres GHESKIO, Port-au-Prince, Haiti.
Jean William PapeLes Centres GHESKIO, Port-au-Prince, Haiti.
Glaucia Paranhos-BaccalaLaboratoire des Pathogènes Emergents (LPE), Fondation Mérieux-Centre International de Recherche en Infectiologie (CIRI), Lyon, France.
Jean-Luc BerlandLaboratoire des Pathogènes Emergents (LPE), Fondation Mérieux-Centre International de Recherche en Infectiologie (CIRI), Lyon, France.

Funding

GHESKIO HIV Clinical Trial UnitUM1AI069421 · NIAID · GHESKIO CENTER · PI JEAN WILLIAM PAPE · 2012 to 2026
$23.6M
GHESKIO HIV Clinical Trial UnitU01AI069421 · NIAID · GHESKIO CENTER · PI PAPE, JEAN WILLIAM · 2007 to 2011
$8.4M
Emory-Georgia TB Research Training ProgramD43TW007124 · FIC · EMORY UNIVERSITY · PI HENRY M BLUMBERG, Nestani Tukvadze · 2004 to 2026
$4.6M
FIC NIH HHS D43 TW007124NIAID NIH HHS UM1 AI069421
6 · The paper itself

Abstract

The emergence of drug-resistant forms of tuberculosis (TB) represents a major public health concern. Understanding the transmission routes of the disease is a key factor for its control and for the implementation of efficient interventions. Mycobacterial interspersed repetitive-unit-variable-number tandem-repeat (MIRU-VNTR) marker typing is a well-described method for lineage identification and transmission tracking. However, the conventional manual genotyping technique is cumbersome and time-consuming and entails many risks for errors, thus hindering its implementation and dissemination. We describe here a new approach using the QIAxcel system, an automated high-throughput capillary electrophoresis system that also carries out allele calling. This automated method was assessed on 1,824 amplicons from 82 TB isolates and tested with sets of markers of 15 or 24 loci. Overall allele-calling concordance between the methods from 140 to 1,317 bp was 98.9%. DNA concentrations and repeatability and reproducibility performances showed no biases in allele calling. Furthermore, turnaround time using this automated system was reduced by 81% compared to the conventional manual agarose gel method. In sum, this new automated method facilitates MIRU-VNTR genotyping and provides reliable results. Therefore, it is well suited for field genotyping. The implementation of this method will help to achieve accurate and cost-effective epidemiological studies, especially in countries with a high prevalence of TB, where the high number of strains complicates the surveillance of circulating lineages and requires efficient interventions to be carried out in an urgent manner.

Indexed as

Genotyping TechniquesMinisatellite RepeatsAutomation, LaboratoryHigh-Throughput Screening AssaysHumansMolecular EpidemiologyMolecular TypingMycobacterium tuberculosisReproducibility of ResultsTime FactorsTuberculosis

Identifiers

PMID25428144
PMCPMC4298502

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.